Global Equity Briefing
Subscribe
Sign in
Home
Start Here
Portfolio
Deep Dives
Investment Cases
Fintech
AI
IREN
Nebius
DLocal
Zeta
Nu
Grab
Emerging Markets
Briefings
For Free Members
Archive
About
Deep Dives
Latest
Top
Discussions
Is Novo Nordisk a BUY?
Novo Nordisk. Equity Research! Part 3/3
Feb 10
•
Ray Myers
8
Blood in the Streets!
Novo Nordisk. Equity Research! Part 2/3
Feb 4
•
Ray Myers
7
2
How Ozempic Transformed Novo Nordisk!
Novo Nordisk. Equity Research! Part 1/3
Jan 28
•
Ray Myers
13
2
3
Is Adyen a great investment?
Adyen. Equity Research! Part 3/3
Aug 9, 2025
•
Ray Myers
20
2
Is Stripe a threat?
Adyen. Equity Research! Part 2/3
Jul 22, 2025
•
Ray Myers
15
4
How Adyen 20X'ed revenues in less than a decade!
Adyen. Equity Research! Part 1/3
Jul 13, 2025
•
Ray Myers
18
7
Is Sea Limited a buy?
Sea Limited. Equity Research! Part 3/3
Jun 8, 2025
•
Ray Myers
8
4
2
Is TikTok Shop a threat?
Sea Limited. Equity Research! Part 2/3
May 25, 2025
•
Ray Myers
10
5
How Sea 30X'ed revenue in 4 years!
Sea Limited. Equity Research! Part 1/3
May 18, 2025
•
Ray Myers
17
1
14
Is Hims a buy?
Hims and Hers. Equity Research! Part 3/3
Apr 27, 2025
•
Ray Myers
12
Is Amazon a threat?
Hims and Hers. Equity Research! Part 2/3
Apr 20, 2025
•
Ray Myers
12
2
2
How Hims grew revenue by 5,434%?
Hims and Hers. Equity Research! Part 1/3
Apr 13, 2025
•
Ray Myers
33
1
21
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts